Vitamin D3 mixed with hydroxychloroquine shows promise in treating COVID-19: Study

A new study finds that COVID-19 patients with acute respiratory infections may improve with a regimen of Vitamin D3, hydroxychloroquine, and azithromycin.

The study was published in the Journal of Steroid Biochemistry and Molecular Biology and employed a randomized controlled trial, considered the gold standard in medical research, on patients who had COVID-19-related pneumonia in a hospital in Spain. All patients were given hydroxychloroquine and azithromycin, and one group was given Vitamin D3 (calcifediol) while the other group was not. Hydroxychloroquine is an “ionophore” that can transport particular molecules across a cell membrane, while azithromycin is an antibiotic used to treat lung infections.